Congressional Investigation of Pharmacy Rebates on Medicaid Drugs
Client Alert | less than 1 min read | 01.16.04
The House Energy and Commerce Committee and its Subcommittee on Oversight and Investigations have asked five large retail pharmacy chains for documents on pharmaceutical reimbursements and rebates under Medicaid. The committee is concerned that drug manufacturers may have been engaged in improper "marketing of the spread," to the detriment of state Medicaid programs. The letters expressed concern that drug manufacturers could be charging low prices on particular prescription medications to their customers, while submitting inaccurate or incomplete cost or price information that becomes the basis of state Medicaid reimbursement for the drug at much higher prices. The January 14th letters were sent to CVS, Eckerd, Rite Aid, Walgreen, and Wal-Mart.
Contacts
Insights
Client Alert | 6 min read | 11.20.26
DOL Proposes Largest PERM Overhaul in Years: What Employers Should Know and Prepare For
On November 17, 2026, the U.S. Department of Labor (DOL) published a notice of proposed rulemaking (NPRM) setting out a Proposed Rule that would significantly change the PERM labor certification process that governs many employer-sponsored green card petitions. While this NPRM proposes nearly a full overhaul of the PERM program, some of the most impactful changes in the Proposed Rule would replace the current labor market test framework, bar certain filings for two years following layoffs, and require employers experiencing relevant post-filing layoffs to offer the sponsored job to affected U.S. workers.
Client Alert | 4 min read | 11.20.26
HHS Finalizes HIPAA Changes to Speed Patient Access, Support Coordinated Care
Client Alert | 4 min read | 11.19.26
Client Alert | 1 min read | 11.19.26
GSA and DHS Launch E-Verify Enforcement Initiative Targeting Contractors

